Status:
TERMINATED
This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid.
Lead Sponsor:
Carolina Neurosurgery & Spine Associates
Conditions:
Spinal Disease
Spinal Radiculopathy
Eligibility:
All Genders
18-65 years
Brief Summary
The objective of this pilot study is to determine if degenerative spinal disorders such as acute radiculopathy, myelopathy, stenosis, or disc and facet disease cause detectable alterations in Substanc...
Eligibility Criteria
Inclusion
- Undergoing spinal surgery for medically refractory spinal radiculopathy,
- myelopathy or neurogenic claudication based on either history, physical examination or radiologic studies demonstrating neural compression or degenerative disc disease.
- Undergoing surgery for medically refractory axial spinal pain.
Exclusion
- Previous spinal procedures or operations,
- radicular pain,
- history of fibromyalgia,
- chronic pain,
- rheumatoid arthritis,
- autoimmune disorders,
- HIV,
- PTSD,
- Major Depressive Disorder,
- migraine headaches or active rhinosinusitis,
- nicotine intake
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT01458938
Start Date
July 1 2009
End Date
April 1 2014
Last Update
February 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carolina Neurosurgery and Spine Associates, P.A.
Charlotte, North Carolina, United States, 28204